Hemoglobin differences by race in children with CKD

Meredith A Atkinson1, Christopher B Pierce, Rachel M Zack

  • 1Division of Pediatric Nephrology, Johns Hopkins University, Baltimore, MD 21287, USA. matkins3@jhmi.edu

Insights

Racial disparities in hemoglobin levels exist in children with chronic kidney disease (CKD). African American children with CKD had lower hemoglobin levels than white children, independent of CKD cause.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Public Health

Background:

  • Racial disparities in anemia are documented in adult chronic kidney disease (CKD).
  • These disparities are less understood in pediatric populations with CKD.

Purpose of the Study:

  • To investigate racial differences in hemoglobin levels among children with CKD.
  • To determine if race is an independent predictor of hemoglobin levels in pediatric CKD.

Main Methods:

  • A cross-sectional analysis of 429 children from the Chronic Kidney Disease in Children (CKiD) Study.
  • Examined the association between race (African American vs. white) and hemoglobin levels using multiple linear regression and generalized gamma modeling.

Main Results:

  • African American children constituted 21% of the cohort.
  • African American children had lower average hemoglobin levels (0.6 g/dL lower) than white children, independent of glomerular filtration rate and CKD diagnosis.
  • Hemoglobin level differences by race were more pronounced at lower hemoglobin concentrations.

Conclusions:

  • African American children with CKD exhibit lower hemoglobin levels compared to white children, irrespective of CKD etiology.
  • These racial disparities in hemoglobin are more evident at the lower end of the hemoglobin distribution in pediatric CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...